Seeing Is Believing
Quoin Pharmaceuticals Ltd DRC's activity chart (see below) currently has 4 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.86% with an average time for these price targets to be met of 381.14 days.
Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 10-Mar-2023. First documented stock forecast 10-Nov-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 10-Mar-2023
$2
3 years 8 months 1 days ago
(10-Mar-2023)
0/1 (0%)
$-4145.5 (-99.95%)
Buy Since 07-Sep-2022
$20
$13.57 (211.04%)
4 years 2 months 4 days ago
(07-Sep-2022)
1/1 (100%)
$-1622.2 (-98.78%)
698
Buy Since 15-Dec-2021
$6300
4 years 2 months 22 days ago
(19-Aug-2022)
0/2 (0%)
$4237.8 (205.50%)
$10
$3.57 (55.52%)
$5
4 years 2 months 23 days ago
(19-Aug-2022)
2/2 (100%)
$-1930.4 (-99.48%)
1272
Buy Since 10-Nov-2016
$1470002
$1469998.38 (40273928.00%)
$1050000
9 years 1 months 16 days ago
(25-Sep-2017)
0/2 (0%)
$592202.06 (67.46%)
What is QNRX (Quoin Pharmaceuticals Ltd DRC) average time for price targets to be met?
Which analyst most recently updated their price target on QNRX (Quoin Pharmaceuticals Ltd DRC)?
Which analyst has the current lower performing score on QNRX (Quoin Pharmaceuticals Ltd DRC) with a proven track record?
Which analyst has the most public recommendations on QNRX (Quoin Pharmaceuticals Ltd DRC)?
Which analyst is the currently most bullish on QNRX (Quoin Pharmaceuticals Ltd DRC)?
Which analyst is the currently most reserved on QNRX (Quoin Pharmaceuticals Ltd DRC)?